Izotropic (TSE:IZO) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Izotropic Corporation, a medical device company specializing in breast CT imaging systems, has restructured its loan terms with its primary lender, leading to an amended principal sum of $2,415,000 with a new maturity date set for September 30, 2024. This revised loan includes accumulated interest and extension fees, with the company having already paid $325,000 in interest payments.
For further insights into TSE:IZO stock, check out TipRanks’ Stock Analysis page.